Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | ADK | P55263 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5624457 | 0.76 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL876246 | 0.76 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL3454835 | 0.73 | — | — | |
| SCHEMBL187790 | 0.72 | — | — | |
| SCHEMBL6368310 | 0.72 | — | — | |
| SCHEMBL8579336 | 0.72 | — | — | |
| SCHEMBL29683638 | 0.72 | — | — | |
| SCHEMBL8579331 | 0.72 | — | — | |
| SCHEMBL1145756 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL28209887 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118598814-A | Preparation method of dexmedetomidine hydrochloride and intermediate thereof | 浙江师范大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-109563049-B | Imidazole compounds as EAAT3 inhibitors | 豪夫迈·罗氏有限公司 | 2022-11-29 | — | — | CN | disclosed |
| EP-3126362-A1 | ANTI-FIBROTIC PYRIDINONES | Intermune, Inc. (US) | 2017-02-08 | — | — | EP | disclosed |
| WO-2015153683-A1 | ANTI-FIBROTIC PYRIDINONES | INTERMUNE, INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| US-9067885-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-06-30 | — | — | US | disclosed |
| US-9040171-B2 | — | — | 2015-05-26 | — | — | US | disclosed |
| EP-2392563-B1 | Nitrogen containing polycyclic derivatives useful in organic light-emitting devices | SAMSUNG DISPLAY CO LTD (KR) | 2014-09-17 | — | — | EP | disclosed |
| US-20110297919-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-12-08 | — | — | US | disclosed |
| EP-2392563-A1 | Nitrogen containing polycyclic derivatives useful in organic light-emitting devices | Samsung Mobile Display Co., Ltd. (KR) | 2011-12-07 | — | — | EP | disclosed |
| US-20110112100-A1 | Hepatitis C Virus Inhibitors | PFIZER INC. | 2011-05-12 | — | — | US | disclosed |
| WO-2011004276-A1 | HEPATITIS C VIRUS INHIBITORS | PFIZER LIMITED (GB) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112100-A1 | Hepatitis C Virus Inhibitors | HAVCR2, SLC10A1, HCCS | ALDH1A1 557/4885SMN1; SMN2 4184/4885NISCH 969/4885 |
| US-20110297919-A1 | ORGANIC LIGHT-EMITTING DEVICE | CRY1, CRY2, CYP2B6 | ALDH1A1 131/4885SMN1; SMN2 2841/4885NISCH 670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.